Our Adult CF Center continues to provide patients with research opportunities in CF. We are proud of the contributions our center and patients have made to the understanding of and therapies for cystic fibrosis. We currently have the following clinical trials:

TOBI dry-powder study— NOW ENROLLING. Eligible patients must have pseudomonas aeruginosa in their sputum. Visit www.aspire-trials.com for more information.

Aztreonam Lysinate for Inhalation (AI or Cayston™) in individuals with CF and Pseudomonas aeruginosa lung infection — CLOSED TO ENROLLMENT, but stay tuned. Visit www.AIR-CF.com for more information.

Genetic Modifier Study — CONTINUING ENROLLMENT

If you are interested in enrolling, or have further questions, please contact:

Judy Hillman, R.N.
215-762-5462
E-mail jhillman@drexelmed.edu